Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial

Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon S. Smith, Tina E. Wood, Ronald L. Korn, Neil Desai, Vuong Trieu, Jose L. Iglesias, Hui Zhang, Patrick Soon-Shiong, Tao Shi, N. V. Rajeshkumar, Anirban Maitra, Manuel Hidalgo

Research output: Contribution to journalArticlepeer-review

757 Scopus citations

Fingerprint Dive into the research topics of 'Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences